Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Aasly

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Neurology|August 9, 2015
UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2(G2019S) carriers and in vivoHeather Mortiboys, Rebecca Furmston, Gunnar Bronstad, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 21, 2015
Familial aggregation of Parkinson's disease in the Faroe IslandsMaria Skaalum Petersen, Sara Bech, Ekaterina Nosova, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 5, 2017
Use of advanced therapies for Parkinson's disease in NorwayBeriwan Ezat, Lasse Pihlstrøm, Jan Aasly, et al.
International Journal of Geriatric Psychiatry|February 15, 2007
Use of the Brief Smell Identification Test for olfactory deficit in a Norwegian population with Alzheimer's diseaseGrete Kjelvik, Sigrid Botne Sando, Jan Aasly, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 12, 2002
Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of Parkinson disease patientsDavid Axelson, Inger Johanne Bakken, Ingrid Susann Gribbestad, et al.
Journal of Parkinson'S Disease|August 14, 2013
Found in transcription: accurate Parkinson's disease classification in peripheral bloodMagdalena Kauczynska Karlsson, Praveen Sharma, Jan Aasly, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 19, 2022
Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related LeukoencephalopathyMorten Andreas Horn, Anders Eivind Myhre, Trine Prescott, et al.
Acta Neuropathologica Communications|November 24, 2017
Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriersShijie Wang, Zhiyong Liu, Tao Ye, et al.
Neurology|September 12, 2022
Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical StageNour Majbour, Jan Aasly, Ilham Abdi, et al.
Neurology|August 17, 2018
Level of residual enzyme activity modulates the phenotype in phosphoglycerate kinase deficiencyJohn Vissing, H Orhan Akman, Jan Aasly, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Neurology|August 9, 2015
UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2(G2019S) carriers and in vivoHeather Mortiboys, Rebecca Furmston, Gunnar Bronstad, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 21, 2015
Familial aggregation of Parkinson's disease in the Faroe IslandsMaria Skaalum Petersen, Sara Bech, Ekaterina Nosova, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 5, 2017
Use of advanced therapies for Parkinson's disease in NorwayBeriwan Ezat, Lasse Pihlstrøm, Jan Aasly, et al.
International Journal of Geriatric Psychiatry|February 15, 2007
Use of the Brief Smell Identification Test for olfactory deficit in a Norwegian population with Alzheimer's diseaseGrete Kjelvik, Sigrid Botne Sando, Jan Aasly, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 12, 2002
Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of Parkinson disease patientsDavid Axelson, Inger Johanne Bakken, Ingrid Susann Gribbestad, et al.
Journal of Parkinson'S Disease|August 14, 2013
Found in transcription: accurate Parkinson's disease classification in peripheral bloodMagdalena Kauczynska Karlsson, Praveen Sharma, Jan Aasly, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 19, 2022
Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R-Related LeukoencephalopathyMorten Andreas Horn, Anders Eivind Myhre, Trine Prescott, et al.
Acta Neuropathologica Communications|November 24, 2017
Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriersShijie Wang, Zhiyong Liu, Tao Ye, et al.
Neurology|September 12, 2022
Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical StageNour Majbour, Jan Aasly, Ilham Abdi, et al.
Neurology|August 17, 2018
Level of residual enzyme activity modulates the phenotype in phosphoglycerate kinase deficiencyJohn Vissing, H Orhan Akman, Jan Aasly, et al.
Pageof 8